Communications Biology,
Год журнала:
2024,
Номер
7(1)
Опубликована: Апрель 9, 2024
The
study
aims
to
explore
the
effect
of
PPARγ
signaling
on
ferroptosis
and
preeclampsia
(PE)
development.
Serum
placental
tissue
are
collected
from
healthy
subjects
PE
patients.
Nrf2
decreases
in
PE.
Rosiglitazone
intervention
reverses
hypoxia-induced
trophoblast
lipid
synthesis
by
regulating
Nfr2
SREBP1.
Compared
Hypoxia
group,
migratory
invasive
abilities
enhance
after
rosiglitazone
ferr1
treatment.
reduces
hypoxia
erastin.
si-Nrf2
treatment
attenuats
effects
proliferation,
migration,
invasion.
does
not
affect
SREBP1
expression.
agonists
alleviates
placenta
rats.
confirms
that
ferroptosis-related
indicators
were
dysregulated
PPARγ/Nrf2
affects
oxidation
rather
than
SREBP1-mediated
synthesis.
In
conclusion,
our
find
can
alleviate
development
ferroptosis.
Cell Death and Disease,
Год журнала:
2023,
Номер
14(3)
Опубликована: Март 21, 2023
Abstract
Ferroptosis
is
an
iron-dependent
regulated
cell
death
driven
by
excessive
lipid
peroxidation.
Inflammation
one
common
and
effective
physiological
event
that
protects
against
various
stimuli
to
maintain
tissue
homeostasis.
However,
the
dysregulation
of
inflammatory
responses
can
cause
imbalance
immune
system,
dysfunction
death.
Recent
studies
have
pointed
out
activation
inflammation,
including
multiple
inflammation-related
signaling
pathways,
lead
ferroptosis.
Among
related
signal
transduction
we
focused
on
five
classical
namely,
JAK-STAT,
NF-κB,
inflammasome,
cGAS-STING
MAPK
expounded
their
roles
in
To
date,
many
agents
shown
therapeutic
effects
ferroptosis-related
diseases
modulating
aforementioned
pathways
vivo
vitro.
Moreover,
regulatory
these
iron
metabolism
peroxidation
been
described
detail,
contributing
further
understanding
pathophysiological
process
Taken
together,
targeting
inflammation
will
provide
appropriate
ways
intervene
ferroptosis
diseases.
Pharmacology & Therapeutics,
Год журнала:
2023,
Номер
244, С. 108373 - 108373
Опубликована: Март 8, 2023
Ferroptosis
is
a
type
of
regulated
cell
death
characterized
by
intracellular
accumulation
iron
and
reactive
oxygen
species,
inhibition
system
Xc-,
glutathione
depletion,
nicotinamide
adenine
dinucleotide
phosphate
oxidation
lipid
peroxidation.
Since
its
discovery
characterization
in
2012,
many
efforts
have
been
made
to
reveal
the
underlying
mechanisms,
modulating
compounds,
involvement
disease
pathways.
inducers
include
erastin,
sorafenib,
sulfasalazine
glutamate,
which,
inhibiting
prevent
import
cysteine
into
cells.
RSL3,
statins,
Ml162
Ml210
induce
ferroptosis
peroxidase
4
(GPX4),
which
responsible
for
preventing
formation
peroxides,
FIN56
withaferin
trigger
GPX4
degradation.
On
other
side,
inhibitors
ferrostatin-1,
liproxstatin-1,
α-tocopherol,
zileuton,
FSP1,
CoQ10
BH4,
interrupt
peroxidation
cascade.
Additionally,
deferoxamine,
deferiprone
N-acetylcysteine,
targeting
cellular
pathways,
also
classified
as
inhibitors.
Increased
evidence
has
established
distinct
brain
diseases,
including
Alzheimer's,
Parkinson's
Huntington's
amyotrophic
lateral
sclerosis,
multiple
Friedreich's
ataxia.
Thus,
deep
understanding
how
contributes
these
it
can
be
modulated,
open
new
window
opportunities
novel
therapeutic
strategies
targets.
Other
studies
shown
sensitivity
cancer
cells
with
mutated
RAS
induction
that
chemotherapeutic
agents
synergize
tumor
treatment.
tempting
consider
may
arise
target
mechanistic
pathway
treatment
tumors.
Therefore,
this
work
provides
an
up-to-date
review
on
molecular
mechanisms
their
diseases.
In
addition,
information
main
targets
provided.
FEBS Journal,
Год журнала:
2022,
Номер
290(7), С. 1688 - 1704
Опубликована: Фев. 2, 2022
Ferroptosis
is
triggered
by
a
chain
of
intracellular
labile
iron-dependent
peroxidation
cell
membrane
phospholipids.
important
not
only
as
cause
ischaemic
and
neurodegenerative
diseases
but
also
mechanism
cancer
suppression,
better
understanding
its
regulatory
required.
It
has
become
clear
that
ferroptosis
finely
controlled
two
oxidative
stress-responsive
transcription
factors,
NRF2
(NF-E2-related
factor
2)
BACH1
(BTB
CNC
homology
1).
inhibit
promote
ferroptosis,
respectively,
activating
or
suppressing
the
expression
genes
in
major
pathways
ferroptosis:
iron
metabolism,
GSH
(glutathione)
-GPX4
(glutathione
peroxidase
4)
pathway
FSP1
(ferroptosis
suppressor
protein
1)-CoQ
(coenzyme
Q)
pathway.
In
addition
to
this,
control
through
regulation
lipid
metabolism
differentiation.
This
multifaceted
considered
have
been
acquired
during
evolution
multicellular
organisms,
allowing
utilization
for
maintaining
homeostasis,
including
suppression.
terms
cell-cell
interaction,
it
revealed
property
propagating
surrounding
cells
along
with
peroxidation.
The
propagation
phenomenon
could
be
used
realize
anticancer
therapy
future.
this
review,
these
points
will
summarized
discussed.
Emerging
evidence
suggests
that
ferroptosis,
a
unique
regulated
cell
death
modality
is
morphologically
and
mechanistically
different
from
other
forms
of
death,
plays
vital
role
in
the
pathophysiological
process
neurodegenerative
diseases,
strokes.
Accumulating
supports
ferroptosis
as
critical
factor
diseases
strokes,
pharmacological
inhibition
therapeutic
target
for
these
diseases.
In
this
review
article,
core
mechanisms
are
overviewed
roles
strokes
described.
Finally,
emerging
findings
treating
through
This
demonstrates
by
bioactive
small-molecule
compounds
(ferroptosis
inhibitors)
could
be
effective
treatments
highlights
potential
promising
avenue
used
to
prevent
article
will
shed
light
on
developing
novel
regimens
slow
down
progression
future.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Дек. 10, 2023
Abstract
Ferroptosis,
a
unique
modality
of
cell
death
with
mechanistic
and
morphological
differences
from
other
modes,
plays
pivotal
role
in
regulating
tumorigenesis
offers
new
opportunity
for
modulating
anticancer
drug
resistance.
Aberrant
epigenetic
modifications
posttranslational
(PTMs)
promote
resistance,
cancer
progression,
metastasis.
Accumulating
studies
indicate
that
can
transcriptionally
translationally
determine
vulnerability
to
ferroptosis
functions
as
driver
nervous
system
diseases
(NSDs),
cardiovascular
(CVDs),
liver
diseases,
lung
kidney
diseases.
In
this
review,
we
first
summarize
the
core
molecular
mechanisms
ferroptosis.
Then,
roles
processes,
including
histone
PTMs,
DNA
methylation,
noncoding
RNA
regulation
such
phosphorylation,
ubiquitination,
SUMOylation,
acetylation,
ADP-ribosylation,
are
concisely
discussed.
The
PTMs
genesis
cancers,
NSD,
CVDs,
well
application
PTM
modulators
therapy
these
then
discussed
detail.
Elucidating
mediated
by
will
facilitate
development
promising
combination
therapeutic
regimens
containing
or
PTM-targeting
agents
inducers
be
used
overcome
chemotherapeutic
resistance
could
prevent
addition,
highlight
potential
approaches
chemoresistance
halt
CNS Neuroscience & Therapeutics,
Год журнала:
2023,
Номер
29(6), С. 1667 - 1677
Опубликована: Фев. 27, 2023
Ferroptosis
is
increasingly
becoming
to
be
considered
as
an
important
mechanism
of
pathological
cell
death
during
stroke,
and
specific
exogenous
ferroptosis
inhibitors
have
the
ability
reverse
cerebral
ischemia/reperfusion
injury.
However,
research
on
Srs11-92
(AA9),
a
ferrostatin-1
(Fer-1)
analog,
in
preclinical
studies
limited.In
middle
artery
occlusion-reperfusion
(MCAO/R)
mice
model
or
oxygen-glucose
deprivation/reperfusion
(OGD/R)
model,
Fer-1,
AA9,
and/or
ML385
were
administered,
brain
infarct
size,
neurological
deficits,
neuronal
damage,
oxidative
stress,
neuroinflammation
determined
after
vitro
vivo.Fer-1
AA9
improved
deficits
MCAO/R,
inhibited
overloaded
iron
deposition,
ROS
accumulation,
response:
it
also
increased
expression
GPx4,
Nrf2,
HO-1
suppressed
HMGB1
NF-κB
p65
epicenter
injured
hippocampal
formation.
Nrf2
inhibitor
reversed
neuroprotective
effect
including
stress
neuroinflammation.
In
showed
that
relieved
OGD/R-induced
via
pathway,
which
was
impaired
by
primary
neurons.The
findings
imply
Fer-1
analog
may
suitable
for
further
translational
protection
damage
signal
pathway-mediated
stroke
others
diseases.
Ageing Research Reviews,
Год журнала:
2023,
Номер
91, С. 102035 - 102035
Опубликована: Авг. 23, 2023
Ferroptosis
is
an
iron-
and
lipid
peroxidation
(LPO)-mediated
programmed
cell
death
type.
Recently,
mounting
evidence
has
indicated
the
involvement
of
ferroptosis
in
neurodegenerative
diseases,
especially
Alzheimer's
disease
(AD),
Parkinson's
(PD),
multiple
sclerosis
(MS),
amyotrophic
lateral
(ALS),
Huntington's
(HD),
so
on.
Treating
presents
opportunities
as
well
challenges
for
diseases.
This
review
provides
a
comprehensive
overview
underlying
mechanisms
that
contribute
to
occurrence
ferroptosis,
their
implications
pathogenesis
advancement
major
disorders.
Meanwhile,
we
summarize
interaction
between
other
types
diseases
contribution
corresponding
drug
development.
In
addition,
specifically
recent
advances
developing
therapeutic
means
targeting
these
which
may
guide
future
approaches
effective
management
devastating
medical
conditions.